News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Elan Corporation PLC Shares Jump on Fresh Talk of Lundbeck Bid
March 26, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
LONDON, March 26 (Reuters) - Shares in Irish biotechnology firm Elan jumped 11 percent on Thursday on market talk Denmark's Lundbeck was lining up an imminent bid at 8 euros per shares, dealers said.
Twitter
LinkedIn
Facebook
Email
Print
Alliances
Mergers & acquisitions
Europe
MORE ON THIS TOPIC
Layoff Tracker
Novartis Continues Cutting Spree With 58 Sacked in New Jersey
September 3, 2025
·
195 min read
·
BioSpace Editorial Staff
Deals
Vertex, Enlaza Declare War on Autoimmune Disease in Potential $2B+ Pact
September 2, 2025
·
2 min read
·
Heather McKenzie
Cancer
Servier Commits up to $530M Into Eye Cancer Deal With IDEAYA
September 2, 2025
·
2 min read
·
Dan Samorodnitsky
Deals
Arrowhead Nabs up to $2B Novartis Commitment for siRNA Parkinson’s Program
September 2, 2025
·
1 min read
·
Annalee Armstrong